R.PR
REGISTERED-PRINCIPAL REGISTER
31/08/2021
Voltar para busca
Dado oficial do USPTO
INHERIT/REVEAL
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
INHERIT/REVEAL
ST13
US500000088910401Classe
1, 42
Pedido
88910401
Registro
6472132
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
31/08/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 42
Data de depósito
11/05/2020
Data de registro
31/08/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
31/08/2021
Última transação
31/08/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
23/11/2020
Primeiro uso no comércio
23/11/2020
Código do desenho
4
Tipo de titular
03
Localização do titular
Natick, MA, US
Examinador
ALLEN, BIANCA LEIGH
Unidade examinadora
N50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Pillar Biosciences, Inc.
Representantes
Marcus Assefa PERKINS COIE LLP
Classificação técnica
Classes Nice
Classe 1Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Reagents and reagent kits comprising nucleic acidsnaturally occurring and modified nucleotidesenzymesbuffersadhesive reagent labelsall for the purpose of preparingdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsregulationstranscriptionsexpressionswith the aforementioned reagents and reagent kits being in the fields of scientific researchclinical researchscientific diagnostics research; Biological and biochemical reagents used for selectively amplifying nucleic acid fragments for scientific researchclinical researchscientific diagnostics research
Classe 42
Software as a service (SaaS)hosting non-downloadable computer software for use by others for collectingmanaginganalyzing data in the fields of scientific researchclinical researchscientific diagnosticsmedical diagnostics; software as a service (SaaS)hosting non-downloadable computer software for use by others for analyzing biological samples; software as a service (SaaS)hosting non-downloadable computer software for use by others for analyzing biological samples for medical purposesfor the diagnosis and treatment of cancer; software as a service (SaaS)hosting non-downloadable computer software for use by others with reagents and reagent kitsall for use in detectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsall in the fields of scientific researchclinical researchscientific diagnostics researchmedical diagnostics; software as a service (Saas)hosting non-downloadable computer software for use by others for bioinformatics and gene expression microarray image analysisgene expression quantificationgene image processinggene information processing; scientific researchcollectionmanagementanalysis of data in the fields of scientific researchclinical research and scientific diagnostics; providing biological sample testing services for others in the fields of scientific researchclinical research and scientific diagnostics; providing reagent sample testing and diagnostic services for othersdetectingsequencinganalyzing nucleic acids and other biological moleculessamples of biological moleculesgenesgenomesnucleotide sequence variants and modificationsall in the fields of scientific researchclinical researchscientific diagnostics research; genetic testing for scientific research purposes in the nature of providing bioinformatics and gene expression microarray image analysis services for othersperforming gene expression quantificationgene image processinggene information processing for others; medical diagnostic researchcollectionmanagementanalysis of data in the field of medical diagnostics
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
28/07/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
27/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/07/2021
ALIE
ASSIGNED TO LIE
02/07/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/05/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/05/2021
EX1G
SOU EXTENSION 1 GRANTED
10/05/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/05/2021
IUAF
USE AMENDMENT FILED
30/04/2021
EXT1
SOU EXTENSION 1 FILED
30/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
30/04/2021
EISU
TEAS STATEMENT OF USE RECEIVED
30/04/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
03/11/2020
DOCK
ASSIGNED TO EXAMINER
20/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/09/2020
PUBO
PUBLISHED FOR OPPOSITION
08/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/08/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/08/2020
DOCK
ASSIGNED TO EXAMINER
06/08/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
21/05/2020
NWAP
NEW APPLICATION ENTERED
14/05/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace INHERIT/REVEAL ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.